Skip to content

Study · Not a test of the peptide alone · 1994

4 results

[Effect of plasmapheresis and immunocorrective therapy on the status of the T-cell component of immunity in patients with autoimmune thyroiditis].

Kalinin AP, Rafibekov DS, Potemkina EE, Shabadin VN

Problemy endokrinologii1 Jul 1994

PMID7971902 (opens in a new tab)PepBankPUB-07971902
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In autoimmune thyroiditis patients, combined plasmapheresis and thymalin therapy produced a stable clinical effect.

    In plain wordsIn autoimmune thyroiditis patients, plasmapheresis and thymalin produced a stable clinical effect.

    Peptide
    Thymalin
    Outcome
    Not applicableStable clinical effect
    Study

    n = 82

    Outcome group
    Overall treatment effect · Endocrine and hormones

    Source sentences

    Summary
    Combined therapy helped attain a stable clinical and immunological effect.
    2 context sentences
    Summary · context
    T-cellular immunity was studied in 104 patients with autoimmune thyroiditis to assess the function of the thyroid and treatment method.
    Summary · context
    In 82 patients it was supplemented with immunocorrective therapy (thymalin) and in 49 with hypothyrosis with substitution therapy (L-thyroxine, thyroidin).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In autoimmune thyroiditis patients, combined plasmapheresis and thymalin therapy produced a stable immunological effect.

    In plain wordsIn autoimmune thyroiditis patients, plasmapheresis and thymalin produced a stable immune effect.

    Peptide
    Thymalin
    Outcome
    Not applicableStable immunological effect
    Study

    n = 82

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Combined therapy helped attain a stable clinical and immunological effect.
    2 context sentences
    Summary · context
    T-cellular immunity was studied in 104 patients with autoimmune thyroiditis to assess the function of the thyroid and treatment method.
    Summary · context
    In 82 patients it was supplemented with immunocorrective therapy (thymalin) and in 49 with hypothyrosis with substitution therapy (L-thyroxine, thyroidin).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In autoimmune thyroiditis patients, T-lymphocyte subpopulation composition recovered after combined therapy including thymalin.

    In plain wordsIn autoimmune thyroiditis patients, T-lymphocyte composition recovered after combined treatment including thymalin.

    Peptide
    Thymalin
    Outcome
    Not applicableT-lymphocyte subpopulation composition
    Study

    n = 82

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Subpopulation composition of T-lymphocytes recovered, their functional activity normalized (follow-up period 1 year).
    2 context sentences
    Summary · context
    T-cellular immunity was studied in 104 patients with autoimmune thyroiditis to assess the function of the thyroid and treatment method.
    Summary · context
    In 82 patients it was supplemented with immunocorrective therapy (thymalin) and in 49 with hypothyrosis with substitution therapy (L-thyroxine, thyroidin).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  4. 04HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In autoimmune thyroiditis patients, T-lymphocyte functional activity normalized after combined therapy including thymalin.

    In plain wordsIn autoimmune thyroiditis patients, T-lymphocyte activity normalized after combined treatment including thymalin.

    Peptide
    Thymalin
    Outcome
    Not applicableT-lymphocyte functional activity
    Study

    n = 82

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Subpopulation composition of T-lymphocytes recovered, their functional activity normalized (follow-up period 1 year).
    2 context sentences
    Summary · context
    T-cellular immunity was studied in 104 patients with autoimmune thyroiditis to assess the function of the thyroid and treatment method.
    Summary · context
    In 82 patients it was supplemented with immunocorrective therapy (thymalin) and in 49 with hypothyrosis with substitution therapy (L-thyroxine, thyroidin).

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.